Glioblastoma Pipeline Shifts to Biomarker-Guided Combination Therapies
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A baseline PET/CT scan's SUVmax independently predicts progression-free survival in EGFR-mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
A ZIF-8-gated cascade nanoreactor converts tumor glucose into hydrogen peroxide and carbon monoxide, depleting ATP and suppressing HSP70 so that ...
New research in The FEBS Journal links mitochondrial DNA copy number in cancer cells to mutational load, tumor growth gene ...
A new review argues that malnutrition in head and neck cancer is driven by tumor metabolism and chronic inflammation rather ...
A retrospective study of 89 patients finds that 18F-FDG PET/CT metabolic parameters, particularly SUVmax, are statistically associated with PD-L1 expression ...
In a groundbreaking study that could reshape the therapeutic landscape for aggressive brain tumors, researchers have identified the amino acid ...
In a world increasingly intrigued by how diet can influence the fate of tumors, new research has shed unexpected light ...
In a groundbreaking study conducted by researchers at the VIB-KU Leuven Center for Cancer Biology, the connection between lung metastasis ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.